Association between a microRNA binding site polymorphism in SLCO1A2 and the risk of delayed methotrexate elimination in Chinese children with acute lymphoblastic leukemia

作者：Wang, Shu-mei^*; Zeng, Wei-xin; Wu, Wan-shui; Suna, Lu-lu; Yan, Dan^*

来源：Leukemia Research, 2018, 65: 61-66.

DOI：10.1016/j.leukres.2018.01.004

• Acute lymphoblastic leukemia
• Methotrexate
• Solute carrier organic anion transporter family member 1A2
• MicroRNA
• Genetic polymorphism

Organic anion-transporting polypeptide 1A2 (OATP1A2) is involved in the cellular uptake of methotrexate (MTX). Genetic variation in solute carrier organic anion transporter family member 1A2 (SLCO1A2, the coding gene of OATP1A2) has important implications for the elimination of MTX. We investigated the association between a microRNA (miRNA) binding site polymorphism (rs4149009 G>A) in the 3'-untranslated region (3'-UTR) of SLCO1A2 with the serum MTX concentrations in Chinese children with acute lymphoblastic leukemia (ALL). Genotyping for SLCO1A2 rs4149009 G>A in 141 children with ALL was performed using the Sequenom MassARRAY system. Serum MTX concentrations were determined by fluorescence polarization immunoassay. The percentages of MTX level >= 1 mu mol/L at 42 h were compared among the AA, GA, and GG genotypes. The minor allele frequency observed in this study (33.0%) was significantly lower than that in the African samples reported in the 1000 Genomes Project (57.4%, P=0.00). The incidence rate of delayed MTX elimination was significantly higher in patients with the GG genotype (23.1%) compared with the AA genotype (0.0%, P=0.03). Bioinformatics tools predicted that the rs4149009 A allele would disrupt the putative binding sites of hsa-miR324-3p and hsa-miR-1913. These results indicate that the rs4149009 G>A polymorphism might affect MTX pharmacokinetics by interfering with the function of miRNAs.

• 出版日期2018-2
• 单位首都医科大学